Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Merck of Whitehouse Station, New Jersey, has halted development of its lead biogeneric product, MK-2578, a PEGylated erythropoietin-stimulating agent for treating anemia. The decision, announced ...

Merck, based in Whitehouse Station, N.J., expects to save about $2.5billion in annual net costs by the end of 2015. It expects to realize $1billion of those savings by the end of 2014. For Merck ...